Article: Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma

File Download Links for fulltext
(May Require Subscription)
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleAberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma
AuthorsWong, MLY
Tao, Q2 5 6
Fu, LI2
Wong, KY
Qiu, GH2
Law, FBF
Tin, PC
Cheung, WL
Lee, PY1
Tang, JCO3 4
Tsao, GSW1
Lam, KY1
Law, S1
Wong, J1
Srivastava, G
Keywords3p21
Methylation
Oesophageal carcinoma
RASSF1A
Tumor suppressor gene
Issue Date2006
PublisherSpandidos Publications. The Journal's web site is located at http://www.spandidos-publications.com/ijo/
CitationInternational Journal Of Oncology, 2006, v. 28 n. 3, p. 767-773 [How to Cite?]
Abstract3p21 is an important locus harbouring critical tumour suppressor genes (TSG), which are implicated in the pathogenesis of multiple tumours, including oesophageal carcinoma. RASSF1A is a 3p21.3 candidate TSG frequently inactivated by promoter methylation in multiple tumours. We investigated RASSF1A promoter methylation and gene expression in Chinese oesophageal squamous cell carcinoma (ESCC) to compare it to data from Japanese patients. Methylation-specific PCR (MSP) showed that RASSF1A was partially methylated in 3/7 (43%) cell lines; 22/64 (34%) primary tumours and 3/64 (5%) corresponding non-tumour samples; and was not methylated in 2 immortalized normal oesophageal epithelial cell lines and 6 normal oesophageal epithelium samples. Bisulfite genome sequencing confirmed the MSP results. Promoter hypermethylation correlated well with RASSF1A mRNA down-regulation. Treatment of cell lines with 5-aza-2′- deoxycytidine activated RASSF1A mRNA expression along with promoter demethylation. RASSF1A hypermethylation in the Chinese cohort was much lower than in a published report of Japanese ESCC patients (52%) and cell lines (74%). Our own analysis of Japanese ESCC cell lines for direct comparison also detected a high frequency of RASSF1A hypermethylation (8/10; 80%) and high levels of hypermethylation at each CpG site. No significant association between RASSF1A hypermethylation and histological differentiation (p=0.953), tumour staging (p=0.117), or survival (p=0.7571) was found in Chinese ESCC, unlike the results of Japanese patients. The incidence of oesophageal cancer shows marked variation by geographic area and ethnic group; it is almost three times higher in China than in Japan, indicating possible different pathogenetic mechanisms. Our results show that RASSF1A hypermethylation in ESCC has epidemiological/ ethnic differences, and suggest that Chinese ESCC may result from different pathogenetic mechanisms.
DescriptionThe article can be viewed at http://www.spandidos-publications.com/ijo/28/3/767
ISSN1019-6439
2011 Impact Factor: 2.399
2011 SCImago Journal Rankings: 0.279
ISI Accession Number IDWOS:000235325000023
ReferencesReferences in Scopus
DC Field
Value
dc.contributor.authorWong, MLY
dc.contributor.authorTao, Q
dc.contributor.authorFu, LI
dc.contributor.authorWong, KY
dc.contributor.authorQiu, GH
dc.contributor.authorLaw, FBF
dc.contributor.authorTin, PC
dc.contributor.authorCheung, WL
dc.contributor.authorLee, PY
dc.contributor.authorTang, JCO
dc.contributor.authorTsao, GSW
dc.contributor.authorLam, KY
dc.contributor.authorLaw, S
dc.contributor.authorWong, J
dc.contributor.authorSrivastava, G
dc.date.accessioned2010-09-06T05:55:41Z
dc.date.available2010-09-06T05:55:41Z
dc.date.issued2006
dc.description.abstract3p21 is an important locus harbouring critical tumour suppressor genes (TSG), which are implicated in the pathogenesis of multiple tumours, including oesophageal carcinoma. RASSF1A is a 3p21.3 candidate TSG frequently inactivated by promoter methylation in multiple tumours. We investigated RASSF1A promoter methylation and gene expression in Chinese oesophageal squamous cell carcinoma (ESCC) to compare it to data from Japanese patients. Methylation-specific PCR (MSP) showed that RASSF1A was partially methylated in 3/7 (43%) cell lines; 22/64 (34%) primary tumours and 3/64 (5%) corresponding non-tumour samples; and was not methylated in 2 immortalized normal oesophageal epithelial cell lines and 6 normal oesophageal epithelium samples. Bisulfite genome sequencing confirmed the MSP results. Promoter hypermethylation correlated well with RASSF1A mRNA down-regulation. Treatment of cell lines with 5-aza-2′- deoxycytidine activated RASSF1A mRNA expression along with promoter demethylation. RASSF1A hypermethylation in the Chinese cohort was much lower than in a published report of Japanese ESCC patients (52%) and cell lines (74%). Our own analysis of Japanese ESCC cell lines for direct comparison also detected a high frequency of RASSF1A hypermethylation (8/10; 80%) and high levels of hypermethylation at each CpG site. No significant association between RASSF1A hypermethylation and histological differentiation (p=0.953), tumour staging (p=0.117), or survival (p=0.7571) was found in Chinese ESCC, unlike the results of Japanese patients. The incidence of oesophageal cancer shows marked variation by geographic area and ethnic group; it is almost three times higher in China than in Japan, indicating possible different pathogenetic mechanisms. Our results show that RASSF1A hypermethylation in ESCC has epidemiological/ ethnic differences, and suggest that Chinese ESCC may result from different pathogenetic mechanisms.
dc.description.natureLink_to_subscribed_fulltext
dc.descriptionThe article can be viewed at http://www.spandidos-publications.com/ijo/28/3/767
dc.identifier.citationInternational Journal Of Oncology, 2006, v. 28 n. 3, p. 767-773 [How to Cite?]
dc.identifier.epage773
dc.identifier.hkuros115158
dc.identifier.isiWOS:000235325000023
dc.identifier.issn1019-6439
2011 Impact Factor: 2.399
2011 SCImago Journal Rankings: 0.279
dc.identifier.issue3
dc.identifier.openurl
dc.identifier.pmid16465383
dc.identifier.scopuseid_2-s2.0-33645237758
dc.identifier.spage767
dc.identifier.urihttp://hdl.handle.net/10722/67500
dc.identifier.volume28
dc.languageeng
dc.publisherSpandidos Publications. The Journal's web site is located at http://www.spandidos-publications.com/ijo/
dc.publisher.placeGreece
dc.relation.ispartofInternational Journal of Oncology
dc.relation.referencesReferences in Scopus
dc.subject.meshCarcinoma, Squamous Cell - epidemiology - genetics - pathology
dc.subject.meshDNA Methylation
dc.subject.meshEsophageal Neoplasms - epidemiology - genetics - pathology
dc.subject.meshPromoter Regions, Genetic - genetics
dc.subject.meshTumor Suppressor Proteins - genetics
dc.subject3p21
dc.subjectMethylation
dc.subjectOesophageal carcinoma
dc.subjectRASSF1A
dc.subjectTumor suppressor gene
dc.titleAberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma
dc.typeArticle
Author Affiliations
  1. The University of Hong Kong
  2. Johns Hopkins Singapore
  3. Hong Kong Polytechnic University
  4. Griffith University
  5. The Johns Hopkins School of Medicine
  6. Chinese University of Hong Kong